Federated Hermes Portfolio holdings
AUM
$53.1B
This Quarter Return
+27.81%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$40.3B
AUM Growth
+$40.3B
(+19%)
Cap. Flow
-$908M
Cap. Flow
% of AUM
-2.25%
Top 10 Holdings %
Top 10 Hldgs %
16.09%
Holding
2,488
New
258
Increased
811
Reduced
1,086
Closed
263
Top Buys
| 1 |
IBM
IBM
|
$243M |
| 2 |
3M
MMM
|
$147M |
| 3 |
Bristol-Myers Squibb
BMY
|
$141M |
| 4 |
Public Service Enterprise Group
PEG
|
$107M |
| 5 |
KeyCorp
KEY
|
$84.8M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$379M |
| 2 |
Kimberly-Clark
KMB
|
$190M |
| 3 |
AbbVie
ABBV
|
$157M |
| 4 |
Altria Group
MO
|
$142M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$119M |
Sector Composition
| 1 | Healthcare | 22.22% |
| 2 | Technology | 18.82% |
| 3 | Consumer Discretionary | 10.59% |
| 4 | Financials | 9.92% |
| 5 | Industrials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Las Vegas Sands
LVS
$38.4B
| $96.6M | 0.24% |
2,121,936
+81,638
| +4% | +$3.72M |
|
102
Thermo Fisher Scientific
TMO
$183B
| $95.4M | 0.24% |
263,340
-18,440
| -7% | -$6.68M |
|
103
Crown Castle
CCI
$43B
| $93.4M | 0.23% |
558,391
-11,558
| -2% | -$1.93M |
|
104
Enbridge
ENB
$105B
| $92.5M | 0.23% |
3,039,336
-132,299
| -4% | -$4.02M |
|
105
Goldman Sachs
GS
$221B
| $92.2M | 0.23% |
466,557
-15,475
| -3% | -$3.06M |
|
106
Tyler Technologies
TYL
$23.9B
| $91.4M | 0.23% |
263,350
-21,949
| -8% | -$7.61M |
|
107
KKR & Co
KKR
$122B
| $89.8M | 0.22% |
2,907,188
-49,936
| -2% | -$1.54M |
|
|
CTLT
108
DELISTED
CATALENT, INC.
CTLT
| $88.4M | 0.22% |
1,206,528
+653,043
| +118% | +$47.9M |
|
109
Etsy
ETSY
$5.15B
| $87.9M | 0.22% |
827,341
+167,010
| +25% | +$17.7M |
|
110
Trex
TREX
$6.42B
| $86.9M | 0.22% |
668,015
-47,140
| -7% | -$6.13M |
|
111
Danaher
DHR
$145B
| $86.3M | 0.21% |
488,256
+87,093
| +22% | +$15.4M |
|
112
Corcept Therapeutics
CORT
$7.6B
| $85.7M | 0.21% |
5,094,181
-122,651
| -2% | -$2.06M |
|
113
Alnylam Pharmaceuticals
ALNY
$59.2B
| $85.4M | 0.21% |
576,469
-15,547
| -3% | -$2.3M |
|
114
HDFC Bank
HDB
$180B
| $84.9M | 0.21% |
1,868,053
+357,644
| +24% | +$16.3M |
|
115
Repligen
RGEN
$6.71B
| $84.6M | 0.21% |
684,325
+46,449
| +7% | +$5.74M |
|
116
Planet Fitness
PLNT
$8.5B
| $84.3M | 0.21% |
1,392,025
+178,390
| +15% | +$10.8M |
|
|
EVBG
117
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $83.7M | 0.21% |
605,279
-159,779
| -21% | -$22.1M |
|
118
Eagle Materials
EXP
$7.24B
| $83.7M | 0.21% |
1,191,789
+135,951
| +13% | +$9.55M |
|
119
Yeti Holdings
YETI
$2.84B
| $83.2M | 0.21% |
1,946,957
+180,450
| +10% | +$7.71M |
|
120
Vulcan Materials
VMC
$38.3B
| $83.1M | 0.21% |
717,099
-88,667
| -11% | -$10.3M |
|
121
Marvell Technology
MRVL
$54.2B
| $83M | 0.21% |
2,368,172
-80,084
| -3% | -$2.81M |
|
|
122
Kimberly-Clark
KMB
$42.4B
| $82.9M | 0.21% |
586,726
-1,344,724
| -70% | -$190M |
|
123
Advanced Micro Devices
AMD
$265B
| $81.3M | 0.2% |
1,545,576
-43,134
| -3% | -$2.27M |
|
124
CRISPR Therapeutics
CRSP
$4.88B
| $79.2M | 0.2% |
1,078,000
| – | – |
|
125
American Electric Power
AEP
$58.8B
| $78.6M | 0.19% |
986,538
+816,896
| +482% | +$65.1M |
|